Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Microsoft Corp. today announced the launch of Microsoft Discovery, a new enterprise-grade artificial intelligence platform ...

"De-extinction" takes center stage as environmentalists express dismay over erosion of the Endangered Species Act ...

Ever since scientists began mapping the human genome, gene editing has always been the end goal. The idea once seemed like ...

Longtime Omaha television reporter John Chapman is honored with his Face on the Barroom Floor at the Omaha Press Club.

"I'm very interested in the concept of reverse-engineering the brain ... chatbot that connects underprivileged kids with public service programs using geospatial mapping. Third in his class, Luca ...

EMI also maps around 50 biotech-focused technology centres across Europe that provide R&D support, mentoring, and product development expertise. Access to technology expertise and facilities for ...

Carlo Ratti's exhibition at the Venice Architecture Biennale 2025 is ambitious, very rich in ideas, projects, researches and ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...